Mice Model Market
Mice Model Market Forecasts to 2030 - Global Analysis By Model Type (Inbred Mice, Genetically Engineered Mice, Hybrid/ Congenic Mice, Outbred Mice, Conditioned/Surgically Modified Mice, Spontaneous Mutant Mice and Other Model Types), Technology, Indication, Application, End User and By Geography
According to Stratistics MRC, the Global Mice Model Market is accounted for $1.5 billion in 2024 and is expected to reach $2.7 billion by 2030 growing at a CAGR of 10.1% during the forecast period. A mice model is a laboratory tool used to study human diseases, biological processes, and drug development due to mice’s genetic similarity to humans. These models help researchers investigate conditions like cancer, neurodegenerative disorders, and cardiovascular diseases. Different types include inbred, outbred, transgenic, knockout, and humanized models, each serving specific research needs. CRISPR-Cas9 and other gene-editing technologies have enhanced the precision of these models for targeted disease studies.
Market Dynamics:
Driver:
Growing need for reliable preclinical models in drug discovery and development
The probability of failure in human research is decreased by the widespread use of mouse models by pharmaceutical and biotechnology companies to assess medication effectiveness and toxicity prior to clinical trials. Mice are perfect for quick and scalable experiments because of their short reproductive cycle and genetic resemblance to humans. The need for mouse models in biomedical research is further increased by regulatory bodies like the FDA and EMA, which want substantial preclinical evidence. The need for sophisticated mouse models for therapeutic research has increased due to the growth in chronic illnesses, such as cancer and neurological disorders.
Restraint:
Ethical concerns and stringent animal testing regulations
Animal rights groups like PETA and HSUS aggressively oppose the use of animal models in research and promote the use of alternative techniques. Research institutes must pay more to comply with strict regulations on animal testing, such as the Animal Welfare Act in the United States and the European Union's REACH. Additionally, there is now more money being spent on alternative models including organoids, in silico simulations, and human-on-a-chip technologies as a result of public pressure and business pledges to decrease animal experimentation hampers the market growth.
Opportunity:
Development of cutting-edge genetic modification techniques
Modern genetic alteration methods, such CRISPR-Cas9, have greatly increased the accuracy of mouse models used in illness research. Better disease modeling for diseases like Alzheimer's, cancer, and autoimmune illnesses is now possible because to scientists' ability to accurately generate knockout, knock-in, and humanized mouse models. Collaborations among pharmaceutical corporations, biotech businesses, and research institutes are also encouraging innovation in the creation of customized mouse models for drug testing and therapeutic breakthroughs.
Threat:
High costs associated with genetically engineered models
Higher research costs are a result of the breeding, housing, and specialized care needed for transgenic and knockout mice. The cost burden frequently prevents university institutions and small research labs from having access to sophisticated mouse models. Additionally, the lengthy development periods for genetically modified models may cause important research initiatives to be postponed, increasing the appeal of less expensive alternatives. The market expansion for mouse models is also threatened by the growing availability of alternative research techniques like 3D cell cultures and AI-driven drug development.
Covid-19 Impact
The COVID-19 pandemic initially disrupted the supply chain for laboratory animals, affecting research timelines and preclinical testing activities. Lockdowns and travel restrictions led to delays in breeding programs and limited access to research facilities, slowing down various biomedical studies. However, the pandemic also highlighted the importance of mice models in vaccine and antiviral drug development. This increased focus on infectious disease models has driven renewed investments in the mice model market, positioning it for long-term growth.
The inbred mice segment is expected to be the largest during the forecast period
The inbred mice segment is expected to account for the largest market share during the forecast period due to its genetic uniformity, which ensures reproducibility and consistency in biomedical research. These mice are extensively used in cancer research, immunology studies, and toxicology testing, making them a preferred choice for pharmaceutical and academic institutions. Additionally, the increasing demand for reliable preclinical models in personalized medicine is further driving the adoption of inbred mice.
The oncology segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the oncology segment is predicted to witness the highest growth rate due to the rising global burden of cancer and the increasing need for advanced preclinical models for cancer research. Mice models play a crucial role in studying tumor biology, testing novel cancer therapies, and evaluating the efficacy of immunotherapies before clinical trials. The demand for genetically engineered mice (GEMs), patient-derived xenograft (PDX) models, and humanized mice has surged as researchers seek accurate models to mimic human tumor microenvironments.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share owing to its well-established research infrastructure, high investments in biomedical research, and strong presence of pharmaceutical companies. The U.S. leads in preclinical research, with extensive funding from organizations like the National Institutes of Health (NIH) and private biotech firms. The region’s growing focus on drug discovery, coupled with advanced genetic engineering capabilities, continues to drive demand for mice models.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR attributed to increasing government support for biomedical research, rising healthcare expenditures, and expanding pharmaceutical industries in countries like China, Japan, and India. Additionally, the adoption of genetically modified mice models is increasing, driven by advancements in gene-editing technologies. Collaborations between Asian research institutes and global pharmaceutical companies are further fueling market expansion in this region.
Key players in the market
Some of the key players in Mice Model market include Allentown LLC, Charles River Laboratories International, Inc., Cyagen Biosciences Inc, Envigo, genOway S.A., Harbour Biomed, Hera Biolabs, Inotiv, Janvier Labs, Ozgene Pty Ltd, PolyGene, Sage Labs, Taconic Biosciences, Inc., The Jackson Laboratory, Trans Genic Inc. and TransCure bioServices .
Key Developments:
In February 2025, HBM Alpha Therapeutics Inc., an innovative biotechnology company incubated by Harbour BioMed, announced a strategic collaboration and license agreement with a business partner to advance novel therapies targeting corticotropin-releasing hormone for various disorders.
In February 2025, Harbour BioMed and Insilico Medicine achieved strategic collaboration to advance AI-driven antibody discovery and development. leveraging their respective technological strengths in antibody discovery and artificial intelligence.
Model Types Covered:
• Inbred Mice
• Genetically Engineered Mice
• Hybrid/ Congenic Mice
• Outbred Mice
• Conditioned/Surgically Modified Mice
• Spontaneous Mutant Mice
• Other Model Types
Technologies Covered:
• CRISPR/Cas9
• Microinjection
• Embryonic Stem Cell Injection
• Nuclear Transfer
• Other Technologies
Indications Covered:
• Oncology
• Cardiovascular Diseases
• Diabetes & Metabolic Disorders
• Immunology & Inflammation
• Central Nervous System Disorders
• Genetic Diseases
• Other Indications
Applications Covered:
• Breeding Services
• Cryopreservation
• Quarantine
• Rederivation
• Genetic Testing
• Model Licensing
• Other Applications
End Users Covered:
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations
• Contract Development & Manufacturing Organizations
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Mice Model Market, By Model Type
5.1 Introduction
5.2 Inbred Mice
5.3 Genetically Engineered Mice
5.4 Hybrid/ Congenic Mice
5.5 Outbred Mice
5.6 Conditioned/Surgically Modified Mice
5.7 Spontaneous Mutant Mice
5.8 Other Model Types
6 Global Mice Model Market, By Technology
6.1 Introduction
6.2 CRISPR/Cas9
6.3 Microinjection
6.4 Embryonic Stem Cell Injection
6.5 Nuclear Transfer
6.6 Other Technologies
7 Global Mice Model Market, By Indication
7.1 Introduction
7.2 Oncology
7.3 Cardiovascular Diseases
7.4 Diabetes & Metabolic Disorders
7.5 Immunology & Inflammation
7.6 Central Nervous System Disorders
7.7 Genetic Diseases
7.8 Other Indications
8 Global Mice Model Market, By Application
8.1 Introduction
8.2 Breeding Services
8.3 Cryopreservation
8.4 Quarantine
8.5 Rederivation
8.6 Genetic Testing
8.7 Model Licensing
8.8 Other Applications
9 Global Mice Model Market, By End User
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.3 Academic & Research Institutes
9.4 Contract Research Organizations
9.5 Contract Development & Manufacturing Organizations
9.6 Other End Users
10 Global Mice Model Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Allentown, LLC
12.2 Charles River Laboratories International, Inc.
12.3 Cyagen Biosciences Inc
12.4 Envigo
12.5 genOway S.A.
12.6 Harbour Biomed
12.7 Hera Biolabs
12.8 Inotiv
12.9 Janvier Labs
12.10 Ozgene Pty Ltd
12.11 PolyGene
12.12 Sage Labs
12.13 Taconic Biosciences, Inc.
12.14 The Jackson Laboratory
12.15 Trans Genic Inc.
12.16 TransCure bioServices
List of Tables
1 Global Mice Model Market Outlook, By Region (2022-2030) ($MN)
2 Global Mice Model Market Outlook, By Model Type (2022-2030) ($MN)
3 Global Mice Model Market Outlook, By Inbred Mice (2022-2030) ($MN)
4 Global Mice Model Market Outlook, By Genetically Engineered Mice (2022-2030) ($MN)
5 Global Mice Model Market Outlook, By Hybrid/ Congenic Mice (2022-2030) ($MN)
6 Global Mice Model Market Outlook, By Outbred Mice (2022-2030) ($MN)
7 Global Mice Model Market Outlook, By Conditioned/Surgically Modified Mice (2022-2030) ($MN)
8 Global Mice Model Market Outlook, By Spontaneous Mutant Mice (2022-2030) ($MN)
9 Global Mice Model Market Outlook, By Other Model Types (2022-2030) ($MN)
10 Global Mice Model Market Outlook, By Technology (2022-2030) ($MN)
11 Global Mice Model Market Outlook, By CRISPR/Cas9 (2022-2030) ($MN)
12 Global Mice Model Market Outlook, By Microinjection (2022-2030) ($MN)
13 Global Mice Model Market Outlook, By Embryonic Stem Cell Injection (2022-2030) ($MN)
14 Global Mice Model Market Outlook, By Nuclear Transfer (2022-2030) ($MN)
15 Global Mice Model Market Outlook, By Other Technologies (2022-2030) ($MN)
16 Global Mice Model Market Outlook, By Indication (2022-2030) ($MN)
17 Global Mice Model Market Outlook, By Oncology (2022-2030) ($MN)
18 Global Mice Model Market Outlook, By Cardiovascular Diseases (2022-2030) ($MN)
19 Global Mice Model Market Outlook, By Diabetes & Metabolic Disorders (2022-2030) ($MN)
20 Global Mice Model Market Outlook, By Immunology & Inflammation (2022-2030) ($MN)
21 Global Mice Model Market Outlook, By Central Nervous System Disorders (2022-2030) ($MN)
22 Global Mice Model Market Outlook, By Genetic Diseases (2022-2030) ($MN)
23 Global Mice Model Market Outlook, By Other Indications (2022-2030) ($MN)
24 Global Mice Model Market Outlook, By Application (2022-2030) ($MN)
25 Global Mice Model Market Outlook, By Breeding Services (2022-2030) ($MN)
26 Global Mice Model Market Outlook, By Cryopreservation (2022-2030) ($MN)
27 Global Mice Model Market Outlook, By Quarantine (2022-2030) ($MN)
28 Global Mice Model Market Outlook, By Rederivation (2022-2030) ($MN)
29 Global Mice Model Market Outlook, By Genetic Testing (2022-2030) ($MN)
30 Global Mice Model Market Outlook, By Model Licensing (2022-2030) ($MN)
31 Global Mice Model Market Outlook, By Other Applications (2022-2030) ($MN)
32 Global Mice Model Market Outlook, By End User (2022-2030) ($MN)
33 Global Mice Model Market Outlook, By Pharmaceutical & Biotechnology Companies (2022-2030) ($MN)
34 Global Mice Model Market Outlook, By Academic & Research Institutes (2022-2030) ($MN)
35 Global Mice Model Market Outlook, By Contract Research Organizations (2022-2030) ($MN)
36 Global Mice Model Market Outlook, By Contract Development & Manufacturing Organizations (2022-2030) ($MN)
37 Global Mice Model Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
